G1 THERAPEUTICS INC's ticker is GTHX and the CUSIP is 3621LQ109. A total of 100 filers reported holding G1 THERAPEUTICS INC in Q4 2019. The put-call ratio across all filers is 17.12 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $313,056 | +50.7% | 217,400 | +160.7% | 0.00% | 0.0% |
Q2 2023 | $207,666 | -71.7% | 83,400 | -69.6% | 0.00% | -50.0% |
Q1 2023 | $734,856 | -57.7% | 274,200 | -14.3% | 0.00% | -60.0% |
Q4 2022 | $1,736,514 | +426.2% | 319,800 | +1111.4% | 0.01% | +400.0% |
Q3 2022 | $330,000 | +108.9% | 26,400 | -17.5% | 0.00% | – |
Q2 2022 | $158,000 | -74.7% | 32,000 | -61.1% | 0.00% | -100.0% |
Q1 2022 | $625,000 | -73.3% | 82,200 | -64.1% | 0.00% | -66.7% |
Q4 2021 | $2,337,000 | -48.6% | 228,916 | -32.4% | 0.01% | -50.0% |
Q3 2021 | $4,546,000 | -61.8% | 338,716 | -37.6% | 0.01% | -61.3% |
Q2 2021 | $11,912,000 | -19.5% | 542,916 | -11.7% | 0.03% | -24.4% |
Q1 2021 | $14,795,000 | +71.4% | 614,916 | +28.2% | 0.04% | +78.3% |
Q4 2020 | $8,632,000 | +582.9% | 479,816 | +338.5% | 0.02% | +475.0% |
Q3 2020 | $1,264,000 | -54.6% | 109,416 | -4.7% | 0.00% | -50.0% |
Q2 2020 | $2,785,000 | +137.0% | 114,816 | +7.7% | 0.01% | +100.0% |
Q1 2020 | $1,175,000 | -24.9% | 106,616 | +80.0% | 0.00% | 0.0% |
Q4 2019 | $1,565,000 | +279.9% | 59,216 | +227.2% | 0.00% | +300.0% |
Q3 2019 | $412,000 | -52.9% | 18,100 | -36.5% | 0.00% | -50.0% |
Q2 2019 | $874,000 | +64.0% | 28,500 | -11.2% | 0.00% | +100.0% |
Q1 2019 | $533,000 | -3.6% | 32,100 | +11.1% | 0.00% | -50.0% |
Q4 2018 | $553,000 | -60.8% | 28,900 | +7.0% | 0.00% | -33.3% |
Q3 2018 | $1,412,000 | +128.8% | 27,000 | +90.1% | 0.00% | +50.0% |
Q2 2018 | $617,000 | – | 14,200 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
MPM BioImpact LLC | 1,423,794 | $34,541,000 | 9.18% |
Burrage Capital Management LLC | 373,876 | $9,070,000 | 6.35% |
Birchview Capital, LP | 40,000 | $970,000 | 0.59% |
361 CAPITAL LLC | 47,325 | $1,148,000 | 0.54% |
Rhenman & Partners Asset Management AB | 190,000 | $4,609,000 | 0.50% |
CHI Advisors LLC | 44,000 | $1,067,000 | 0.42% |
Bellevue Group AG | 721,925 | $17,514,000 | 0.25% |
Candriam S.C.A. | 870,423 | $21,117,000 | 0.22% |
Virtus ETF Advisers LLC | 18,991 | $461,000 | 0.22% |
HHLR ADVISORS, LTD. | 949,431 | $23,033,000 | 0.21% |